Multiple regenerative and hypertrophy-related pathways in autologous adipose-derived mesenchymal stem cells and chondrocytes

The term Multiple regenerative and hypertrophy-related pathways in autologous adipose-derived mesenchymal stem cells and chondrocytes refers to the complex signaling network that governs the therapeutic interaction between adipose-derived mesenchymal stem cells (ADMSCs) and articular chondrocytes. In regenerative medicine, particularly for osteoarthritis, autologous ADMSCs are used to promote cartilage repair by secreting paracrine factors and exosomes that activate regenerative pathways such as TGF-beta/Smad, BMP, and Wnt/beta-catenin signaling. These pathways stimulate chondrocytes to proliferate and synthesize hyaline-like extracellular matrix components, including Type II collagen and aggrecan. Simultaneously, these interactions aim to inhibit hypertrophy-related pathways, such as those mediated by Runx2 and Indian Hedgehog (Ihh), which otherwise lead to chondrocyte terminal differentiation, Type X collagen expression, and eventual tissue calcification. The balance between these opposing signaling cascades is critical for the success of cell-based therapies like JointStem, as it determines whether the resulting tissue is functional hyaline cartilage or dysfunctional fibrocartilage. Therapeutic strategies often focus on modulating these pathways to enhance the chondrogenic potential of ADMSCs while preventing the hypertrophic fate that often plagues stem cell-derived cartilage. While not a single molecular target, this system represents a multi-faceted therapeutic mechanism involving various receptors (e.g., TGFBR, BMPR) and transcription factors (e.g., Sox9, Runx2). Understanding this interplay is essential for developing effective treatments for degenerative joint diseases and ensuring the long-term stability of regenerated cartilage.

Other names

ADMSC-chondrocyte signaling crosstalkMSC-mediated chondrogenesisCartilage regenerative signalingADMSC paracrine signaling in osteoarthritis

Modulation of paracrine signaling cascades, including TGF-beta, BMP, and Wnt pathways, to promote chondrogenic differentiation and suppress hypertrophic markers in chondrocytes.